You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Diabetes and other endocrinal, nutritional and metabolic conditions
  5. Diabetes

Diabetes in pregnancy: management from preconception to the postnatal period

  • NICE guideline
  • Reference number: NG3
  • Published:  25 February 2015
  • Last updated:  16 December 2020
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Research recommendations coming out of this guidance

  • What are the roles of insulin pump therapy (continuous subcutaneous insulin infusion) and
    continuous glucose monitoring in helping women with diabetes to achieve blood glucose targets
    before pregnancy?

  • When should testing for gestational diabetes take place – in the first or second trimester?

  • What are the barriers that women experience to achieving blood glucose targets?

  • How can fetuses at risk of intrauterine death be identified in women with diabetes?

  • Are there effective long-term pharmacological interventions to prevent the onset of type 2
    diabetes that can be recommended postnatally for women who have been diagnosed with
    gestational diabetes?

  • In women with type 1 diabetes who are planning to become pregnant, what is the most effective method of glucose monitoring to improve maternal and baby outcomes:

    • continuous glucose monitoring

    • flash glucose monitoring

    • intermittent capillary blood glucose monitoring?

  • In women with type 1 diabetes who are already pregnant, what is the most effective method of glucose monitoring to improve maternal and baby outcomes:

    • continuous glucose monitoring

    • flash glucose monitoring?

Back to top